PAHC
HealthcarePhibro Animal Health Corporation
$38.37
+$1.07 (+2.87%)
Jan 5, 2026
Price History (1Y)
Analysis
Phibro Animal Health Corporation is a healthcare company operating in the drug manufacturers - specialty & generic sector. With a market capitalization of $1.56B and annual revenue of $1.40B, the company has a significant presence in its industry. Phibro employs 2475 individuals. The company's financial health appears to be robust. Its profitability is evident through gross margin of 31.7%, operating margin of 13.4%, and profit margin of 4.8%. Returns on equity and assets stand at 23.8% and 8.6%, respectively, indicating a strong return on investment. The balance sheet shows cash reserves of $85.89M and debt of $788.52M, resulting in a debt to equity ratio of 252.99. Phibro's valuation context is characterized by a price-to-earnings ratio (TTM) of 22.31 and forward P/E of 12.71. The company has experienced significant revenue growth at 39.7% year-over-year, accompanied by earnings growth of 282.4%. While the dividend yield stands at 129.0%, the payout ratio is relatively low at 28.7%.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Phibro Animal Health Corporation
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in developing, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, copper, manganese, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for use in personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 1946 and is headquartered in Teaneck, New Jersey.
Visit website →Key Statistics
- Market Cap
- $1.56B
- P/E Ratio
- 22.31
- 52-Week High
- $46.42
- 52-Week Low
- $16.16
- Avg Volume
- 287.35K
- Beta
- 0.78
- Dividend Yield
- 129.00%
Company Info
- Exchange
- NGM
- Country
- United States
- Employees
- 2,475